Congratulations to the ICAN project team!

The ICAN Study (Immunoglobulin use and outcomes in Chronic lymphocytic leukaemia And Non-Hodgkin lymphoma) conducted by the LaRDR is closing out today. The study overcame the challenge of recruiting participants during the covid pandemic. We reached (beyond) the recruitment target of 500 patients! Dr Khaili Chai led the analyses and presented the preliminary results during the 2022 BLOOD conference.

We would like to thank all the ICAN investigators, participating hospital sites, and participants for their contribution to the study.

Photo (left to right): Dr Khaili Chai, Ms Eliza Chung, Dr Laura Sellick